Tag Archives: Regulatory
Pharma Companies Feeling the Heat From the Sunshine Act
Last week marked the release of the initial data from the Sunshine Act law of the Affordable Care Act, which had been dreaded by many health care professionals and pharmaceutical and medical device executives. So, for the past few years,
Competitive Intelligence Guidelines & Policies Keeping Companies in the Safety Zone
Competitive Intelligence (CI) groups are instrumental in helping world-class companies to anticipate and respond strategically to external change. Primary and secondary competitive intelligence research helps organizations to improve their chances for success in today’s competitive business environment. While there are
Best Practices in Structuring & Staffing Pharma Government Affairs’ Groups
The Government Affairs and Public Policy functions play an important role in the Pharmaceutical industry. Both functions are involved in critical areas such as legislative affairs, reimbursement, and regulatory, making it essential for organizations to have not only appropriate staffing
Best Practices in Delivering MSL Services to Diverse Customer Groups
Biopharmaceutical & Medical Device companies often struggle with the challenge of delivering exceptional services to a diverse set of customers. On top of this, concerns about compliance and legal limitations are forcing companies to re-examine how their medical science liaisons